ENCell Signs 600 Million Won Biopharmaceutical Supply Contract

ENCell announced on April 20 that it has signed a contract worth 600 million won for the manufacture and supply of advanced biopharmaceuticals.

The contract amount represents 11.41% of the company's sales, which total approximately 5.26 billion won. The contract period runs from today until July 31, 2027.

The company explained, "The payment will be made in installments according to the completion of each phase, starting with a 100 million won down payment, followed by steps such as aseptic process simulation and the production of investigational drugs."

This content was produced with the assistance of AI translation services.